Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci185128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Mengmeng Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Atherosclerosis, Apolipoprotein A-I, Cysteine Endopeptidases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Scientists of National Natural Science Foundation of China; Guangzhou Science and Technology Program key projects;Shenzhen Natural Science Founda….
Abstract (Originalsprache)
Atherosclerosis is a slowly progressing inflammatory disease characterized with cholesterol disorder and intimal plaques. Asparagine endopeptidase (AEP) is an endolysosomal protease that is activated under acidic conditions and is elevated substantially in both plasma and plaques of patients with atherosclerosis. However, how AEP accelerates atherosclerosis development remains incompletely understood, especially from the view of cholesterol metabolism. This project aims to reveal the crucial substrate of AEP during atherosclerosis plaque formation and to lay the foundation for developing novel therapeutic agents for Atherosclerosis. Here, we show that AEP is augmented in the atherosclerosis plaques obtained from patients and proteolytically cuts apolipoprotein A1 (APOA1) and impairs cholesterol efflux and high-density lipoprotein (HDL) formation, facilitating atherosclerosis pathologies. AEP is activated in the liver and aorta of apolipoprotein E–null (APOE-null) mice, and deletion of AEP from APOE –/– mice attenuates atherosclerosis. APOA1, an essential lipoprotein in HDL for cholesterol efflux, is cleaved by AEP at N208 residue in the liver and atherosclerotic macrophages of APOE –/– mice. Blockade of APOA1 cleavage by AEP via N208A mutation or its specific inhibitor, #11a, substantially diminishes atherosclerosis in both APOE –/– and LDLR –/– mice. Hence, our findings support that AEP disrupts cholesterol metabolism and accelerates the development of atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
- Faculty of Life and Health Sciences, Shenzhen University of Advanced Technology (SUAT), University of Chinese Academy of Science, Shenzhen, Guangdong, China.
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
- Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
- Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, International Campus, Zhejiang University, Haining, China.
- Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Scienc…
Förderung
- International Scientists of National Natural Science Foundation of China; Guangzhou Science and Technology Program key projects;Shenzhen Natural Science Founda…
Zitieren
APA
Wang, M., Li, B., Nie, S., Meng, X., Wang, G., Yang, M., Dang, W., He, K., Sun, T., Xu, P., Yang, X., & Ye, K. (2025). Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis. Journal of Clinical Investigation. https://doi.org/10.1172/jci185128
Vancouver
Wang M, Li B, Nie S, Meng X, Wang G, Yang M, et al. Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis. Journal of Clinical Investigation. 2025. doi:10.1172/jci185128
BibTeX
@article{Wang2025,
author = {Wang, Mengmeng and Li, Bowei and Nie, Shuke and Meng, Xin and Wang, Guangxing and Yang, Menghan and Dang, Wenxin and He, Kangning and Sun, Tucheng and Xu, Ping and Yang, Xifei and Ye, Keqiang},
title = {Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci185128}
}
EUVIMED